Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Role of diagnostic laparoscopy in patients with large cell neuroendocrine carcinoma of the ovary with cancerous peritonitis: case report and review of the literature

Fig. 3

Kaplan-Meier survival curves for overall survival of LCNEC patients. The total 5-year survival is 34.6%, and median survival time is 17 months in all LCNEC patients (n = 53) (a). There are no significant differences between the cases with FIGO stage I/II (n = 28) and III/IV (n = 25), with total 5-year survival of 38.8 and 29.2% and median survival time of 19 and 9 months, respectively (p = 0.458) (b). The cases with carcinomatous peritonitis (n = 11) show significantly much worse clinical outcomes than cases without carcinomatous peritonitis (n = 42), with median survival time of 20 and 7 months, respectively (p = 0.036) (c)

Back to article page